OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gene expression profiling of diffuse large B-Cell lymphomas supervised by CD5 expression
Kana Miyazaki, Motoko Yamaguchi, Hiroshi Imai, et al.
International Journal of Hematology (2015) Vol. 102, Iss. 2, pp. 188-194
Closed Access | Times Cited: 26
Kana Miyazaki, Motoko Yamaguchi, Hiroshi Imai, et al.
International Journal of Hematology (2015) Vol. 102, Iss. 2, pp. 188-194
Closed Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Treatment of Diffuse Large B-Cell Lymphoma
Kana Miyazaki
Journal of Clinical and Experimental Hematopathology (2016) Vol. 56, Iss. 2, pp. 79-88
Open Access | Times Cited: 64
Kana Miyazaki
Journal of Clinical and Experimental Hematopathology (2016) Vol. 56, Iss. 2, pp. 79-88
Open Access | Times Cited: 64
Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI
Joel Wight, Geoffrey Chong, Andrew Grigg, et al.
Blood Reviews (2018) Vol. 32, Iss. 5, pp. 400-415
Closed Access | Times Cited: 60
Joel Wight, Geoffrey Chong, Andrew Grigg, et al.
Blood Reviews (2018) Vol. 32, Iss. 5, pp. 400-415
Closed Access | Times Cited: 60
Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL ) reveals gain at 1q31 and RGS 1 encoding protein; high RGS 1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS )
Joaquim Carreras, Yara Yukie Kikuti, Sı́lvia Beà, et al.
Histopathology (2016) Vol. 70, Iss. 4, pp. 595-621
Closed Access | Times Cited: 50
Joaquim Carreras, Yara Yukie Kikuti, Sı́lvia Beà, et al.
Histopathology (2016) Vol. 70, Iss. 4, pp. 595-621
Closed Access | Times Cited: 50
Treatments and Outcomes of Newly Diagnosed CD5‐Positive Diffuse Large B‐Cell Lymphoma: A Multi‐Institutional Observational Study
Yuma Nato, Kana Miyazaki, Dai Maruyama, et al.
Hematological Oncology (2025) Vol. 43, Iss. 2
Open Access
Yuma Nato, Kana Miyazaki, Dai Maruyama, et al.
Hematological Oncology (2025) Vol. 43, Iss. 2
Open Access
CD5 and p53 immunohistochemistry: valuable prediction method in molecular typing of CD5-positive diffuse large B-cell lymphoma
Han Wang, Huaxiong Pan, Liling Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Han Wang, Huaxiong Pan, Liling Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
CD5 positivity is an independent adverse prognostic factor in elderly patients with diffuse large B cell lymphoma
Wen‐Yu Chuang, Hung Chang, Lee‐Yung Shih, et al.
Virchows Archiv (2015) Vol. 467, Iss. 5, pp. 571-582
Closed Access | Times Cited: 35
Wen‐Yu Chuang, Hung Chang, Lee‐Yung Shih, et al.
Virchows Archiv (2015) Vol. 467, Iss. 5, pp. 571-582
Closed Access | Times Cited: 35
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study
Kana Miyazaki, Naoko Asano, Tomomi Yamada, et al.
Haematologica (2019) Vol. 105, Iss. 9, pp. 2308-2315
Open Access | Times Cited: 31
Kana Miyazaki, Naoko Asano, Tomomi Yamada, et al.
Haematologica (2019) Vol. 105, Iss. 9, pp. 2308-2315
Open Access | Times Cited: 31
MYD88,CD79B, andCARD11gene mutations in CD5-positive diffuse large B-cell lymphoma
Toshifumi Takeuchi, Motoko Yamaguchi, Kyoko Kobayashi, et al.
Cancer (2016) Vol. 123, Iss. 7, pp. 1166-1173
Open Access | Times Cited: 26
Toshifumi Takeuchi, Motoko Yamaguchi, Kyoko Kobayashi, et al.
Cancer (2016) Vol. 123, Iss. 7, pp. 1166-1173
Open Access | Times Cited: 26
CD5+ diffuse large B-cell lymphoma: a narrative review
Urshila Durani, Stephen M. Ansell
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 62, Iss. 13, pp. 3078-3086
Closed Access | Times Cited: 19
Urshila Durani, Stephen M. Ansell
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 62, Iss. 13, pp. 3078-3086
Closed Access | Times Cited: 19
De Novo CD5+ Diffuse Large B-Cell Lymphoma: Biology, Mechanism, and Treatment Advances
Yichen Xu, Sun Wen-jie, Fei Li
Clinical Lymphoma Myeloma & Leukemia (2020) Vol. 20, Iss. 10, pp. e782-e790
Open Access | Times Cited: 20
Yichen Xu, Sun Wen-jie, Fei Li
Clinical Lymphoma Myeloma & Leukemia (2020) Vol. 20, Iss. 10, pp. e782-e790
Open Access | Times Cited: 20
Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review
Penelope Korkolopoulou, Theodoros P. Vassilakopoulos, Vassilios Milionis, et al.
Advances in Anatomic Pathology (2016) Vol. 23, Iss. 4, pp. 202-243
Closed Access | Times Cited: 19
Penelope Korkolopoulou, Theodoros P. Vassilakopoulos, Vassilios Milionis, et al.
Advances in Anatomic Pathology (2016) Vol. 23, Iss. 4, pp. 202-243
Closed Access | Times Cited: 19
Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatment
Lingchuan Guo, Pei Lin, Hui Xiong, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1869, Iss. 2, pp. 85-96
Closed Access | Times Cited: 17
Lingchuan Guo, Pei Lin, Hui Xiong, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1869, Iss. 2, pp. 85-96
Closed Access | Times Cited: 17
Clinicopathologic significance and therapeutic implication of de novo CD5+ diffuse large B-cell lymphoma
Huifen Tang, Hui Zhou, Juying Wei, et al.
Hematology (2019) Vol. 24, Iss. 1, pp. 446-454
Open Access | Times Cited: 16
Huifen Tang, Hui Zhou, Juying Wei, et al.
Hematology (2019) Vol. 24, Iss. 1, pp. 446-454
Open Access | Times Cited: 16
High Expression of the SH3TC2-DT/SH3TC2 Gene Pair Associated With FLT3 Mutation and Poor Survival in Acute Myeloid Leukemia: An Integrated TCGA Analysis
Pengfei Yu, Hai-Feng Lan, Xianmin Song, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 14
Pengfei Yu, Hai-Feng Lan, Xianmin Song, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 14
Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B‐cell lymphoma in a Japanese cohort
Tatsuzo Mishina, Nagisa Oshima‐Hasegawa, Shokichi Tsukamoto, et al.
British Journal of Haematology (2021) Vol. 195, Iss. 5, pp. 731-742
Open Access | Times Cited: 11
Tatsuzo Mishina, Nagisa Oshima‐Hasegawa, Shokichi Tsukamoto, et al.
British Journal of Haematology (2021) Vol. 195, Iss. 5, pp. 731-742
Open Access | Times Cited: 11
Expressions of SH 3BP 5, LMO 3, and SNAP 25 in diffuse large B‐cell lymphoma cells and their association with clinical features
Kyoko Kobayashi, Motoko Yamaguchi, Kana Miyazaki, et al.
Cancer Medicine (2016) Vol. 5, Iss. 8, pp. 1802-1809
Open Access | Times Cited: 11
Kyoko Kobayashi, Motoko Yamaguchi, Kana Miyazaki, et al.
Cancer Medicine (2016) Vol. 5, Iss. 8, pp. 1802-1809
Open Access | Times Cited: 11
Novel blood-based hypomethylation of SH3BP5 is associated with very early-stage lung adenocarcinoma
Rong Qiao, Runbo Zhong, Chunlan Liu, et al.
Genes & Genomics (2021) Vol. 44, Iss. 4, pp. 445-453
Closed Access | Times Cited: 9
Rong Qiao, Runbo Zhong, Chunlan Liu, et al.
Genes & Genomics (2021) Vol. 44, Iss. 4, pp. 445-453
Closed Access | Times Cited: 9
Molecular subtyping of CD5+ diffuse large B-cell lymphoma based on DNA-targeted sequencing and Lymph2Cx
Dongshen Ma, Yuhan Ma, Yuanyuan Ma, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Dongshen Ma, Yuhan Ma, Yuanyuan Ma, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphoma
Hyun‐Young Kim, Mi‐Ae Jang, Hee‐Jin Kim, et al.
Blood Research (2017) Vol. 52, Iss. 3, pp. 193-193
Open Access | Times Cited: 7
Hyun‐Young Kim, Mi‐Ae Jang, Hee‐Jin Kim, et al.
Blood Research (2017) Vol. 52, Iss. 3, pp. 193-193
Open Access | Times Cited: 7
Lenalidomide combined with R-GDP in a patient with refractory CD5-positive diffuse large B-cell lymphoma: A promising response and review
Yaping Zhang, Xinfeng Wang, Yifei Liu, et al.
Cancer Biology & Therapy (2018) Vol. 19, Iss. 7, pp. 549-553
Open Access | Times Cited: 7
Yaping Zhang, Xinfeng Wang, Yifei Liu, et al.
Cancer Biology & Therapy (2018) Vol. 19, Iss. 7, pp. 549-553
Open Access | Times Cited: 7
De Novo CD5-positive diffuse large B-cell lymphoma: A genomic profiling study and prognostic analysis of 46 patients
Yue Fan, Ouyang Binshen, Zhihan Zhang, et al.
Annals of Diagnostic Pathology (2022) Vol. 58, pp. 151886-151886
Closed Access | Times Cited: 4
Yue Fan, Ouyang Binshen, Zhihan Zhang, et al.
Annals of Diagnostic Pathology (2022) Vol. 58, pp. 151886-151886
Closed Access | Times Cited: 4
CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma
Jie Sun, Xiaoquan Zhu, Yanyang Zhao, et al.
Pharmacogenomics and Personalized Medicine (2021) Vol. Volume 14, pp. 397-408
Open Access | Times Cited: 4
Jie Sun, Xiaoquan Zhu, Yanyang Zhao, et al.
Pharmacogenomics and Personalized Medicine (2021) Vol. Volume 14, pp. 397-408
Open Access | Times Cited: 4
Identification of CD5/SOX11 double-negative pleomorphic mantle cell lymphoma
Wen‐Yu Chuang, Hung Chang, Lee‐Yung Shih, et al.
Virchows Archiv (2024) Vol. 485, Iss. 2, pp. 323-334
Closed Access
Wen‐Yu Chuang, Hung Chang, Lee‐Yung Shih, et al.
Virchows Archiv (2024) Vol. 485, Iss. 2, pp. 323-334
Closed Access
Clinicopathologic Features and Genomic Signature of De Novo CD5+ Diffuse Large B-Cell Lymphoma
Wei Sang, Yuhan Ma, Xiangmin Wang, et al.
The American Journal of Surgical Pathology (2022) Vol. 46, Iss. 11, pp. 1533-1544
Closed Access | Times Cited: 2
Wei Sang, Yuhan Ma, Xiangmin Wang, et al.
The American Journal of Surgical Pathology (2022) Vol. 46, Iss. 11, pp. 1533-1544
Closed Access | Times Cited: 2
Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice
Satomi Sahashi, Kazuyuki Shimada, Yusuke Takagi, et al.
International Journal of Hematology (2023) Vol. 118, Iss. 2, pp. 221-230
Closed Access
Satomi Sahashi, Kazuyuki Shimada, Yusuke Takagi, et al.
International Journal of Hematology (2023) Vol. 118, Iss. 2, pp. 221-230
Closed Access
